126 related articles for article (PubMed ID: 9145236)
1. Tiludronate inhibits protein tyrosine phosphatase activity in osteoclasts.
Murakami H; Takahashi N; Tanaka S; Nakamura I; Udagawa N; Nakajo S; Nakaya K; Abe M; Yuda Y; Konno F; Barbier A; Suda T
Bone; 1997 May; 20(5):399-404. PubMed ID: 9145236
[TBL] [Abstract][Full Text] [Related]
2. A possible mechanism of the specific action of bisphosphonates on osteoclasts: tiludronate preferentially affects polarized osteoclasts having ruffled borders.
Murakami H; Takahashi N; Sasaki T; Udagawa N; Tanaka S; Nakamura I; Zhang D; Barbier A; Suda T
Bone; 1995 Aug; 17(2):137-44. PubMed ID: 8554921
[TBL] [Abstract][Full Text] [Related]
3. Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts.
Insogna K; Tanaka S; Neff L; Horne W; Levy J; Baron R
Mol Reprod Dev; 1997 Jan; 46(1):104-8. PubMed ID: 8981371
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine phosphorylation of p130Cas is involved in actin organization in osteoclasts.
Nakamura I; Jimi E; Duong LT; Sasaki T; Takahashi N; Rodan GA; Suda T
J Biol Chem; 1998 May; 273(18):11144-9. PubMed ID: 9556601
[TBL] [Abstract][Full Text] [Related]
5. The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me(v)/me(v) mutant mice.
Aoki K; Didomenico E; Sims NA; Mukhopadhyay K; Neff L; Houghton A; Amling M; Levy JB; Horne WC; Baron R
Bone; 1999 Sep; 25(3):261-7. PubMed ID: 10495129
[TBL] [Abstract][Full Text] [Related]
6. Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption.
Nakamura I; Takahashi N; Sasaki T; Tanaka S; Udagawa N; Murakami H; Kimura K; Kabuyama Y; Kurokawa T; Suda T
FEBS Lett; 1995 Mar; 361(1):79-84. PubMed ID: 7890044
[TBL] [Abstract][Full Text] [Related]
7. [Possible mechanism of the specific action of bisphosphonates on osteoclasts].
Udagawa N
Nihon Rinsho; 2003 Feb; 61(2):207-12. PubMed ID: 12638209
[TBL] [Abstract][Full Text] [Related]
8. Activation of Src kinase by protein-tyrosine phosphatase-PEST in osteoclasts: comparative analysis of the effects of bisphosphonate and protein-tyrosine phosphatase inhibitor on Src activation in vitro.
Chellaiah MA; Schaller MD
J Cell Physiol; 2009 Aug; 220(2):382-93. PubMed ID: 19350555
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin-induced changes in the cytoskeleton are mediated by a signal pathway associated with protein kinase A in osteoclasts.
Suzuki H; Nakamura I; Takahashi N; Ikuhara T; Matsuzaki K; Isogai Y; Hori M; Suda T
Endocrinology; 1996 Nov; 137(11):4685-90. PubMed ID: 8895334
[TBL] [Abstract][Full Text] [Related]
10. Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts.
Woo JT; Kasai S; Stern PH; Nagai K
J Bone Miner Res; 2000 Apr; 15(4):650-62. PubMed ID: 10780857
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of focal adhesion kinase, p125FAK, in osteoclastic bone resorption.
Tanaka S; Takahashi N; Udagawa N; Murakami H; Nakamura I; Kurokawa T; Suda T
J Cell Biochem; 1995 Aug; 58(4):424-35. PubMed ID: 7593264
[TBL] [Abstract][Full Text] [Related]
12. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
[TBL] [Abstract][Full Text] [Related]
13. Destruxins, cyclodepsipeptides, block the formation of actin rings and prominent clear zones and ruffled borders in osteoclasts.
Nakagawa H; Takami M; Udagawa N; Sawae Y; Suda K; Sasaki T; Takahashi N; Wachi M; Nagai K; Woo JT
Bone; 2003 Sep; 33(3):443-55. PubMed ID: 13678787
[TBL] [Abstract][Full Text] [Related]
14. Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate.
Schmidt A; Rutledge SJ; Endo N; Opas EE; Tanaka H; Wesolowski G; Leu CT; Huang Z; Ramachandaran C; Rodan SB; Rodan GA
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3068-73. PubMed ID: 8610169
[TBL] [Abstract][Full Text] [Related]
15. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.
Duong LT; Lakkakorpi PT; Nakamura I; Machwate M; Nagy RM; Rodan GA
J Clin Invest; 1998 Sep; 102(5):881-92. PubMed ID: 9727056
[TBL] [Abstract][Full Text] [Related]
16. Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts.
Nakamura I; Takahashi N; Sasaki T; Jimi E; Kurokawa T; Suda T
J Bone Miner Res; 1996 Dec; 11(12):1873-9. PubMed ID: 8970888
[TBL] [Abstract][Full Text] [Related]
17. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.
David P; Nguyen H; Barbier A; Baron R
J Bone Miner Res; 1996 Oct; 11(10):1498-507. PubMed ID: 8889850
[TBL] [Abstract][Full Text] [Related]
18. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.
Coxon FP; Helfrich MH; Van't Hof R; Sebti S; Ralston SH; Hamilton A; Rogers MJ
J Bone Miner Res; 2000 Aug; 15(8):1467-76. PubMed ID: 10934645
[TBL] [Abstract][Full Text] [Related]
19. Quercetin suppresses bone resorption by inhibiting the differentiation and activation of osteoclasts.
Woo JT; Nakagawa H; Notoya M; Yonezawa T; Udagawa N; Lee IS; Ohnishi M; Hagiwara H; Nagai K
Biol Pharm Bull; 2004 Apr; 27(4):504-9. PubMed ID: 15056855
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells.
Jimi E; Nakamura I; Duong LT; Ikebe T; Takahashi N; Rodan GA; Suda T
Exp Cell Res; 1999 Feb; 247(1):84-93. PubMed ID: 10047450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
